Skip to main content
Atrás
Watch Compare

PLIANT THERAPEUTICS, INC.

Calidad de datos: 100%
PLRX
Nasdaq Manufacturing Chemicals
$1.36
▼ $0.01 (-0.37%)
Cap. Mercado: 83.89 M
Precio
$1.36
Cap. Mercado
83.89 M
Rango del Día
$1.32 — $1.37
Rango de 52 Semanas
$1.09 — $1.95
Volumen
188,908
Apertura $1.36
Promedio 50D / 200D
$1.26
7.81% above
Promedio 50D / 200D
$1.42
4.91% below

Quick Summary

Puntos Clave

Debt/Equity of 0.15 — conservative balance sheet
Negative free cash flow of -128.71 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-71.05%
Below sector avg (-53.41%)
ROIC-45.91%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
0.15
Below sector avg (0.31)
Current Ratio13.93
Interest Coverage-61.11

Valoración

PE (TTM)
-0.56
Above sector avg (-1.48)
P/B Ratio0.42
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.6 -1.5
P/B 0.4 1.6
ROE % -71.1 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 0.2 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -149.34 M
ROE -71.05% ROA -51.82%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -128.71 M
ROIC -45.91% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.15 Current Ratio 13.93
Interest Coverage -61.11 Asset Turnover 0.00
Working Capital 227.96 M Tangible Book Value 200.31 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.56 Forward P/E N/A
P/B Ratio 0.42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -153.42%
Market Cap 83.89 M Enterprise Value 20.60 M
Per Share
EPS (Diluted TTM) -2.43 Revenue / Share 0.00
FCF / Share -2.08 OCF / Share -2.07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.18%
SBC-Adj. FCF -159.32 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 1.58 M 9.69 M 7.57 M
Net Income -149.34 M -210.30 M -161.34 M -123.32 M -97.26 M
EPS (Diluted) -2.43 -3.47 -2.75 -2.94 -2.71
Gross Profit — — — — —
Operating Income -156.37 M -228.37 M -184.15 M -127.20 M -97.54 M
EBITDA — — — — —
R&D Expenses 109.16 M 169.31 M 127.80 M 96.94 M 77.55 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2.56 M 3.02 M 1.27 M 0.0 —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 225.23 M 396.95 M 512.15 M 350.61 M 221.22 M
Total Liabilities 44.02 M 92.87 M 38.58 M 37.27 M 22.16 M
Shareholders' Equity 181.21 M 304.08 M 473.58 M 313.34 M 199.06 M
Total Debt 0.0 30.21 M 10.05 M 9.93 M —
Cash & Equivalents 45.45 M 71.19 M 63.23 M 33.69 M 51.67 M
Current Assets 196.45 M 362.26 M 505.50 M 340.31 M 209.44 M
Current Liabilities 16.37 M 33.22 M 28.52 M 23.91 M 16.83 M